Nyxoah Posts Strong Q3 Results, Gears Up for Genio’s Anticipated US Launch

Summary: Nyxoah reported third-quarter financial results, showcasing a 30% increase in sales and raising €24.6 million to bolster its anticipated US commercialization of the Genio neurostimulation system for obstructive sleep apnea. The company also highlighted progress in its US operations, including the presentation of promising DREAM study data and key leadership hires to drive the…

Read More

High Temperatures Immediately Worsen Sleep Apnea Severity, Study Shows

Summary: A large-scale national study using wearable smart devices has revealed that high temperatures can worsen obstructive sleep apnea (OSA) symptoms, including increasing apnea-hypopnea index (AHI) and lowering minimum oxygen saturation (MinSpO2). The study analyzed over 6 million days of sleep data from more than 51,000 participants in 313 Chinese cities, finding that elevated temperatures…

Read More

A Specific Brain Function Monitor Could Be Useful During DISE

Summary: A Stanford University study found that Masimo SedLine’s Patient State Index effectively monitors sedation depth during drug-induced sleep endoscopy with dexmedetomidine, providing a more reliable assessment of brain state changes than traditional methods. This improvement could enhance sedation management for sleep apnea therapy evaluations. Key Takeaways: Potential for Broader Use of Dexmedetomidine: Improved sedation…

Read More

Two Sleep-Focused Innovators Among MedTech Finalists Set to Compete

Summary:MedTech Innovator has announced the finalists for its Mid-Stage and Value Award Competitions, with Ozlo and Somnics Health among those selected. Ozlo, based in Boston, is developing Bluetooth earbuds for uninterrupted sleep, while Somnics Health, based in Redwood City, Calif, is working on a portable treatment for obstructive sleep apnea. The competitions will take place…

Read More

Narcolepsy Insights from Alkermes Presented at Psych Congress and NEI Congress

Summary: Alkermes presented new research on its investigational narcolepsy treatment, ALKS 2680, as well as findings on the patient experience of narcolepsy at two scientific conferences: the 37th Annual Psych Congress and the 2024 Neuroscience Education Institute Congress. The data includes safety and efficacy results from a phase 1b study of ALKS 2680, a selective…

Read More

NIH to Fund $747K Study on Link Between Sleep and Brain Health

Summary: University at Buffalo researcher Carleara Weiss, PhD, RN, has received a $747,000 grant from the National Institute on Aging to explore the link between sleep health, neurodegeneration biomarkers, and cognitive decline in older adults. This study will examine the effects of nicotinamide riboside, a form of vitamin B3, on sleep and memory, while monitoring…

Read More